EICHOR
● Completed
A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Condition: Thyroid Eye Disease · Sponsor: Viridian Therapeutics, Inc.
About this study
This is a clinical trial assessing the safety, tolerability and pharmacokinetics (PK) of an investigational drug, VRDN-003, in participants with TED (Thyroid Eye Disease)
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (13)
| United Medical Research Institute | Inglewood, California, United States | — |
| C&A Clinical Trials Corp | Cape Coral, Florida, United States | — |
| Ilumina Medical Research | Kissimmee, Florida, United States | — |
| Med-Care Research | Miami, Florida, United States | — |
| Continental Clinical Research, llc | Miami, Florida, United States | — |
| Hype Clinical Research, LLC | Miami, Florida, United States | — |
| Advanced Quality Medical Research, LLC | Orland Park, Illinois, United States | — |
| Ophthalmic Consultants of Boston | East Weymouth, Massachusetts, United States | — |
| Fraser Eye Center | Fraser, Michigan, United States | — |
| Kahana Oculoplastic and Orbital Surgery | Livonia, Michigan, United States | — |
| Vector Clinical Trials | Sparks, Nevada, United States | — |
| Baylor College of Medicine, Alkek Eye Center | Houston, Texas, United States | — |
+ 1 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.